JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M104217200 on July 5, 2001

J. Biol. Chem., Vol. 276, Issue 36, 34098-34104, September 7, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/36/34098    most recent
M104217200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, Z.-L.
Right arrow Articles by Hulme, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, Z.-L.
Right arrow Articles by Hulme, E. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Transmembrane Domains 4 and 7 of the M1 Muscarinic Acetylcholine Receptor Are Critical for Ligand Binding and the Receptor Activation Switch*

Zhi-Liang LuDagger §, Jose W. Saldanha, and Edward C. HulmeDagger

From the Divisions of Dagger  Physical Biochemistry and  Mathematical Biology, Medical Research Council National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom

Activation of the muscarinic acetylcholine receptors requires agonist binding followed by a conformational change, but the ligand binding and conformation-switching residues have not been completely identified. Systematic alanine-scanning mutagenesis has been used to assess residues 142-164 in transmembrane helix 4 and 402-421 in transmembrane helix 7 of the M1 muscarinic acetylcholine receptor. Several inward-facing amino acid side chains in the exofacial parts of transmembrane helices 4 and 7 contribute to acetylcholine binding. Alanine substitution of the aromatic residues in this group reduced signaling efficacy, suggesting that they may form part of a charge-stabilized aromatic cage, which triggers rotation and movement of the transmembrane helices. The mutation of adjacent residues modulated receptor activation, either reducing signaling or causing constitutive activation. In the buried endofacial section of transmembrane helix 7, alanine substitution mutants of the conserved NSXXNPXXY motif displayed strongly reduced signaling efficacy, despite having increased or unchanged acetylcholine affinity. These residues may have dual functions, forming intramolecular contacts that stabilize the receptor in the inactive ground state, but that are broken, allowing them to form new intramolecular bonds in the activated state. This conformational rearrangement is critical to produce a G protein binding site and may represent a key mechanism of receptor activation.


* This work was supported by the Medical Research Council, UK.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Tel.: 44-20-8959-3666; Fax: 44-20-8906-4477; E-mail: zlu@nimr.mrc.ac.uk.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J. A. Goodwin, E. C. Hulme, C. J. Langmead, and B. G. Tehan
Roof and Floor of the Muscarinic Binding Pocket: Variations in the Binding Modes of Orthosteric Ligands
Mol. Pharmacol., December 1, 2007; 72(6): 1484 - 1496.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Bee and E. C. Hulme
Functional Analysis of Transmembrane Domain 2 of the M1 Muscarinic Acetylcholine Receptor
J. Biol. Chem., November 2, 2007; 282(44): 32471 - 32479.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z.-L. Lu, M. Coetsee, C. D. White, and R. P. Millar
Structural Determinants for Ligand-Receptor Conformational Selection in a Peptide G Protein-coupled Receptor
J. Biol. Chem., June 15, 2007; 282(24): 17921 - 17929.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Mamputha, Z.-l. Lu, R. W. Roeske, R. P. Millar, A. A. Katz, and C. A. Flanagan
Conserved Amino Acid Residues that Are Important for Ligand Binding in the Type I Gonadotropin-Releasing Hormone (GnRH) Receptor Are Required for High Potency of GnRH II at the Type II GnRH Receptor
Mol. Endocrinol., January 1, 2007; 21(1): 281 - 292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. Hawtin, J. Simms, M. Conner, Z. Lawson, R. A. Parslow, J. Trim, A. Sheppard, and M. Wheatley
Charged Extracellular Residues, Conserved throughout a G-protein-coupled Receptor Family, Are Required for Ligand Binding, Receptor Activation, and Cell-surface Expression
J. Biol. Chem., December 15, 2006; 281(50): 38478 - 38488.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Ding, J. K. Rainey, C. Xu, B. D. Sykes, and L. Fliegel
Structural and Functional Characterization of Transmembrane Segment VII of the Na+/H+ Exchanger Isoform 1
J. Biol. Chem., October 6, 2006; 281(40): 29817 - 29829.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
E. C. Hulme, A. K. Soper, S. E. McLain, and J. L. Finney
The Hydration of the Neurotransmitter Acetylcholine in Aqueous Solution
Biophys. J., September 15, 2006; 91(6): 2371 - 2380.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
T. Muramatsu and M. Suwa
Statistical analysis and prediction of functional residues effective for GPCR-G-protein coupling selectivity
Protein Eng. Des. Sel., June 1, 2006; 19(6): 277 - 283.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Fruchart-Gaillard, G. Mourier, C. Marquer, A. Menez, and D. Servent
Identification of Various Allosteric Interaction Sites on M1 Muscarinic Receptor Using 125I-Met35-Oxidized Muscarinic Toxin 7
Mol. Pharmacol., May 1, 2006; 69(5): 1641 - 1651.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z.-L. Lu, R. Gallagher, R. Sellar, M. Coetsee, and R. P. Millar
Mutations Remote from the Human Gonadotropin-releasing Hormone (GnRH) Receptor-binding Sites Specifically Increase Binding Affinity for GnRH II but Not GnRH I: EVIDENCE FOR LIGAND-SELECTIVE, RECEPTOR-ACTIVE CONFORMATIONS
J. Biol. Chem., August 19, 2005; 280(33): 29796 - 29803.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-J. Han, F. F. Hamdan, S.-K. Kim, K. A. Jacobson, L. Brichta, L. M. Bloodworth, J. H. Li, and J. Wess
Pronounced Conformational Changes following Agonist Activation of the M3 Muscarinic Acetylcholine Receptor
J. Biol. Chem., July 1, 2005; 280(26): 24870 - 24879.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
I. Ben-Shlomo and A. J. W. Hsueh
Three's Company: Two or More Unrelated Receptors Pair with the Same Ligand
Mol. Endocrinol., May 1, 2005; 19(5): 1097 - 1109.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Sur, P. J. Mallorga, M. Wittmann, M. A. Jacobson, D. Pascarella, J. B. Williams, P. E. Brandish, D. J. Pettibone, E. M. Scolnick, and P. J. Conn
N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-D-aspartate receptor activity
PNAS, November 11, 2003; 100(23): 13674 - 13679.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Schmidt, B. Li, L. Bloodworth, I. Erlenbach, F.-Y. Zeng, and J. Wess
Random Mutagenesis of the M3 Muscarinic Acetylcholine Receptor Expressed in Yeast: IDENTIFICATION OF POINT MUTATIONS THAT "SILENCE" A CONSTITUTIVELY ACTIVE MUTANT M3 RECEPTOR AND GREATLY IMPAIR RECEPTOR/G PROTEIN COUPLING
J. Biol. Chem., August 8, 2003; 278(32): 30248 - 30260.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Y. Seong, L. Wang, D. Y. Oh, O. Yun, K. Maiti, J. H. Li, J. M. Soh, H. S. Choi, K. Kim, H. Vaudry, et al.
Ala/Thr201 in Extracellular Loop 2 and Leu/Phe290 in Transmembrane Domain 6 of Type 1 Frog Gonadotropin-Releasing Hormone Receptor Confer Differential Ligand Sensitivity and Signal Transduction
Endocrinology, February 1, 2003; 144(2): 454 - 466.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Furukawa, T. Hamada, M. K. Hayashi, T. Haga, Y. Muto, H. Hirota, S. Yokoyama, K. Nagasawa, and M. Ishiguro
Conformation of Ligands Bound to the Muscarinic Acetylcholine Receptor
Mol. Pharmacol., October 1, 2002; 62(4): 778 - 787.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Prioleau, I. Visiers, B. J. Ebersole, H. Weinstein, and S. C. Sealfon
Conserved Helix 7 Tyrosine Acts as a Multistate Conformational Switch in the 5HT2C Receptor. IDENTIFICATION OF A NOVEL "LOCKED-ON" PHENOTYPE AND DOUBLE REVERTANT MUTATIONS
J. Biol. Chem., September 20, 2002; 277(39): 36577 - 36584.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. A. Spalding, C. Trotter, N. Skjarbak, T. L. Messier, E. A. Currier, E. S. Burstein, D. Li, U. Hacksell, and M. R. Brann
Discovery of an Ectopic Activation Site on the M1 Muscarinic Receptor
Mol. Pharmacol., June 1, 2002; 61(6): 1297 - 1302.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Manivet, B. Schneider, J. C. Smith, D.-S. Choi, L. Maroteaux, O. Kellermann, and J.-M. Launay
The Serotonin Binding Site of Human and Murine 5-HT2B Receptors. MOLECULAR MODELING AND SITE-DIRECTED MUTAGENESIS
J. Biol. Chem., May 3, 2002; 277(19): 17170 - 17178.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.